Equity Research Reports, Company Report, Profile, SWOT: Ken Research

Equity Research Report

The equity research reports will provide an independent opinion on management viewpoint on companies growth, company future strategy, company positioning in the sector along with financial statement forecasting, ratio analysis and relative valuation or precedent transaction analysis.

Show entries

Showing repository of 42084 reports

Product Title

Published (yyyy-mm-dd)

Pages

Price (USD)

Helomics Corp-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Summary

Helomics Corp(Helomics) is a life science company that develops and offers precision medicine support tools and services for cancer treatment. The company's products include chemofx, biospecifx, genefx colon and genefx lung. Its ch
Read More

2018-03-12

250

Jiuzhitang Co Ltd (000989)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Summary

Jiuzhitang Co Ltd (Jiuzhitang), formerly Labor Jiuzhitang Pharmacy is a medicinal products company that offers Chinese traditional medicines. The company's products include Yi ling oral liquid, liu wei di huang wan, qijudihuang pil
Read More

2018-03-12

250

Hadassah Medical Center-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Summary

Hadassah Medical Center (HMC) is a healthcare service provider that offers patient care services. The center offers anesthesiology and critical care medicine, bone marrow transplantation and cancer immunotherapy, cardiology, cardio
Read More

2018-03-12

250

Invetech Pty Ltd-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Summary

Invetech Pty Ltd (Invetech), a subsidiary of Danaher Corp is a manufacturer of custom automation systems. The company offers services which include product development, instrument development, custom automation and contract manufac
Read More

2018-03-12

250

Humabs BioMed SA-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Summary

Humabs BioMed SA (Humabs) is an antibody therapeutics biotechnology company that discovers and develops human monoclonal antibodies. The company's pipeline programs include Flu A virus, ebola virus, HBV, rabies virus, JCV, dengue,
Read More

2018-03-12

250

GigaGen Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Summary

GigaGen Inc (GigaGen) is a pre-clinical biotherapeutics company that discovers and develops monoclonal and polyclonal antibody therapies and T cell therapies derived from immune repertoires. The company's single cell sequencing and
Read More

2018-03-12

250

Galecto Biotech AB-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Summary

Galecto Biotech AB (Galecto Biotech) is a biotech company that focuses on the development of novel drugs for the treatment of fibrosis, inflammation, and other diseases. The company's products act against galectins or galactoside b
Read More

2018-03-12

250

Genmedica Therapeutics SL-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Summary

Genmedica Therapeutics SL (Genmedica) is a clinical-stage biopharmaceutical company that researches, discovers and develops orally available NCEs for the treatment of diabetes. The company's expertise spans in the development of sp
Read More

2018-03-12

250

IRLAB Therapeutics AB (IRLAB A)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Summary

IRLAB Therapeutics AB (IRL) is a pharmaceutical company that discovers and develops drugs to treat central nervous system (CNS) associated diseases. Its flagship technology integrative screening process (ISP), a phenotypic screenin
Read More

2018-03-12

250

Idorsia Ltd (IDIA)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Summary

Idorsia Ltd (Idorsia) is a biopharmaceutical company that discovers, develops various therapies. The pipeline portfolio of the company includes investigational candidates targeted at the treatment of resistant hypertension, chronic
Read More

2018-03-12

250